| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/24/2006 | US20060188512 Active immunization to generate antibodies to solble a-beta |
| 08/24/2006 | CA2598316A1 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 08/24/2006 | CA2598080A1 Amyloid-binding peptides, analogues and uses thereof |
| 08/23/2006 | EP1692157A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 08/23/2006 | EP1692104A1 Methods of preparing compounds useful as protease inhibitors |
| 08/23/2006 | EP1692098A1 Alpha-ketoamide derivative, and production method and use thereof |
| 08/23/2006 | EP1691818A2 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 08/23/2006 | EP1691814A2 Anti-inflammatory agents |
| 08/23/2006 | EP1648923A4 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 08/23/2006 | EP1648922A4 Spatially-defined macrocyclic compounds useful for drug discovery |
| 08/23/2006 | EP1507794B1 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 08/23/2006 | EP1171452B1 Pyrrolidincarbolylamino cyclic disulfides as vcam-vla4 antagonists |
| 08/23/2006 | EP0914827B1 Ophthalmic drug compositions |
| 08/22/2006 | US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 08/22/2006 | US7094870 Crystals of oxidized glutathione and process for producing the same |
| 08/22/2006 | US7094869 Animal growth regulators |
| 08/22/2006 | US7094868 Peptides for recognition and targeting of GLIAL cell tumors |
| 08/22/2006 | US7094760 Peptides for treatment of inflammation and shock |
| 08/17/2006 | WO2006086098A2 Mass spectrometric methods and products |
| 08/17/2006 | WO2006085332A1 Improved process for preparation of highly pure trandolapril |
| 08/17/2006 | WO2006059164A3 Pyrrolopyridine-2-carboxylic acid amides |
| 08/17/2006 | WO2005056754A3 Compositions and methods to reduce mutagenesis |
| 08/17/2006 | WO2003087124A3 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells |
| 08/17/2006 | US20060183920 more especially its tert-butylamine salt; synthesis intermediates; carried out in the presence of an activation reagent selected from N-methyl-N-phenyl-aminotriphenylphosphonium iodide and hexamethylphosphorus triamide together with ammonium perchlorate by Mitsunobu reaction |
| 08/17/2006 | US20060183883 C5a Receptor antagonists |
| 08/17/2006 | US20060183732 Novel lactams and uses thereof |
| 08/17/2006 | US20060183694 Serine protease inhibition via 1-{[1-(2-Methoxycarbonylamino-3,3-dimethyl-butyryl)-4-(7-methoxy-2-phenyl-quinolin-4-yloxy)-pyrrolidine-2-carbonyl]-amino}-2-vinyl-cyclopropanecarboxylic acid |
| 08/17/2006 | US20060183691 Anti-hypertensive molecules and process for preparation thereof |
| 08/17/2006 | US20060183690 Fish protein hydrolysates (Salmo or Oncorhynchus); for inhibiting angiotensin converting enzyme |
| 08/17/2006 | US20060183209 Fusion protein for use in genration of preferential biopolymers in plants |
| 08/17/2006 | US20060183177 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 08/16/2006 | EP1690869A1 Peptide inhibiting angiontensin converting enzyme |
| 08/16/2006 | EP1689852A2 Compositions and methods to reduce mutagenesis |
| 08/16/2006 | EP1689770A1 Depeptidized inhibitors of hepatitis c virus ns3 protease |
| 08/16/2006 | EP1689711A1 Method for producing n- 1-(s)-carbalkoxy-3-phenylpropyl|-s-alanyl-2s, 3ar, 7as-octahydroindol-2-carboxylic acid compounds |
| 08/16/2006 | EP1578777A4 Iap binding compounds |
| 08/16/2006 | EP1252192B1 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | CN1820025A Fluorescein-labelled peptides |
| 08/16/2006 | CN1819841A Methods of enhancing immune induction involving mda-7 |
| 08/16/2006 | CN1819837A TAMANDARIN analogs and fragments thereof and methods of making and using |
| 08/16/2006 | CN1269817C Dehalogeno compounds |
| 08/16/2006 | CN1269801C Amino acid derivatives and drug containing the same as the active ingredient |
| 08/16/2006 | CN1269776C Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 08/16/2006 | CN1269477C Inflammation-inhibiting compounds |
| 08/15/2006 | US7091364 Introducing in a reactor a5-amino-3-(carboxyalkyl)-4-cyano-2-thiophenecarboxylic acid, potassium carbonate and a quaternaryammonium salt as catalyst acetone solvent and methyl bromo acetate, heating and cooling |
| 08/15/2006 | US7091321 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/15/2006 | US7091313 Coupling a solid support derived from polystyrene with N-protected derivative of amino acid, removing N-protecting group, coupling the product thus obtained with N-protected derivative of amino acid; removing protecting group, repeating the procedure, coupling, cyclization |
| 08/15/2006 | US7091186 p-Amidobenzylethers in drug delivery agents |
| 08/15/2006 | US7091184 Hepatitis C inhibitor tri-peptides |
| 08/15/2006 | US7091175 activating neovascularization by administering heptapeptides having replacements in the amino acid sequence; antiischemic agents; regeneration and maintenance of artificial bones |
| 08/15/2006 | US7090999 preparing pristinamycin IIA and/or IIB by introducing a disabling mutation into a gene that encodes 3-hydroxypicolinic acid:adenosine 5'-monopiosphate ligase; selecting and culturing cells containing the mutated gene that are blocked in the production of pristinamycin IA and IB |
| 08/15/2006 | US7090828 Vitronectin receptor antagonist pharmaceuticals |
| 08/10/2006 | WO2006083266A1 Inhibitors of bacterial type iii protein secretion systems |
| 08/10/2006 | WO2006050861A3 Statine derivatives for the treatment of alzheimer's disease |
| 08/10/2006 | WO2005118621A3 Omi pdz modulators |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | US20060179492 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating |
| 08/10/2006 | US20060178421 Hydrogenation catalysts |
| 08/10/2006 | US20060178315 For therapy of immune or autoimmune diseases |
| 08/10/2006 | US20060178312 Process for the production of melagatran |
| 08/10/2006 | US20060178310 Intracellular delivery of biological effectors |
| 08/10/2006 | US20060177893 Method for producing dipeptides |
| 08/09/2006 | EP1688486A1 Antibacterial peptide and utilization of the same |
| 08/09/2006 | EP1688482A1 Method for producing L-amino acid using bacteria belonging to the genus Escherichia |
| 08/09/2006 | EP1688427A1 Perindopril |
| 08/09/2006 | EP1687304A1 Substituted quinolines for the treatment of cancer |
| 08/09/2006 | EP1687021A1 Method of removing transition metals, especially from metathesis reaction products |
| 08/09/2006 | EP1687018A1 Hepatitis c virus inhibitors |
| 08/09/2006 | EP1513868B1 Process for the production of lisinopril |
| 08/09/2006 | EP1290032B1 Antibodies against particular forms of propsa and use thereof in immunoassays |
| 08/09/2006 | EP1177197B1 Polyamines and their use in therapy |
| 08/09/2006 | EP1075796B1 Sweetener compositions |
| 08/09/2006 | EP1037650B1 Compositions for the treatment of staphylococcus aureus infections |
| 08/09/2006 | CN1268762C Corn peptide and its preparation and use |
| 08/09/2006 | CN1268742C Peptide synthase gene, peptide synthase and process for producing dipdptide |
| 08/09/2006 | CN1268618C 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 08/08/2006 | US7087776 Silanol enzyme inhibitors |
| 08/08/2006 | US7087717 Comprises nucleotide sequences coding nuclear hormone receptor co-activator for diagnosis and treatment of liver disorders |
| 08/08/2006 | US7087600 Anticancer agents; side effect reduction |
| 08/08/2006 | US7087576 Dipeptide phenyl ethers |
| 08/08/2006 | US7087229 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/03/2006 | WO2006079934A2 Inhibition of sweat malodour |
| 08/03/2006 | WO2006057997A3 Plasmin-inhibitory therapies |
| 08/03/2006 | WO2005117940A9 Cell death modulation via antagonists of fasl and fas activation |
| 08/03/2006 | WO2005074641A3 Variant neuronal nicotinic alpha-7 receptor and methods of use |
| 08/03/2006 | WO2005049651A3 Cancer diagnosis and therapy |
| 08/03/2006 | WO2004007680A3 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing an adenosine kinase |
| 08/03/2006 | US20060172952 Aza-peptide epoxides |
| 08/03/2006 | US20060172950 Hepatitis C virus inhibitors |
| 08/03/2006 | US20060172931 Heparin-binding peptides and uses thereof |
| 08/03/2006 | US20060172291 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 08/02/2006 | EP1685439A1 Translating bifocal wear modality |
| 08/02/2006 | EP1684788A2 Peptide increasing fusiogenic capacity of a gamete |
| 08/02/2006 | EP1684787A1 Hepatitis c virus inhibitors |
| 08/02/2006 | EP1684745A2 Hepatitis c virus inhibitors |
| 08/02/2006 | CN1810828A Fatty acid-carnosine composite and its prepn |
| 08/01/2006 | US7084250 asymmetric hydrogenation of 2-[2-acetylamino-3-(4-cyanophenyl)acryloylamino]-2-cyclohexylacetic acid and conversion of the cyano group into the amidine, or a salt thereof, with a 3-(2-amino-2-carbamoylethyl)-1-methylpyridinium salt; claimed intermediates |
| 08/01/2006 | US7084249 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 08/01/2006 | US7084246 Epidermal growth factor agonists |